Finance

Lists
Why is 300255 up 3.20%?
Dive Deeper
300255:SHE
Hebei Changshan Biochemical Pharm Co Ltd
CNÂ¥19.33
+3.20%
(+0.60) 1D
Oct 28, 3:04:22 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300255...
Open
CNÂ¥18.85
High
CNÂ¥19.54
Low
CNÂ¥18.81
Mkt. cap
17.77B
Avg. vol.
18.02M
Volume
16.15M
52-wk high
CNÂ¥71.71
52-wk low
CNÂ¥18.36
EPS
-CNÂ¥0.38
Shares outstanding
919.06M
No. of employees
1K
Open
CNÂ¥18.85
High
CNÂ¥19.54
Low
CNÂ¥18.81
Mkt. cap
17.77B
Avg. vol.
18.02M
Volume
16.15M
52-wk high
CNÂ¥71.71
52-wk low
CNÂ¥18.36
EPS
-CNÂ¥0.38
Shares outstanding
919.06M
No. of employees
1K
News stories
From web sources and news partners
About Hebei Changshan Biochemical Pharm Co Ltd
CEO-
Employees1.19K
Founded1992
Headquarters-
SectorPharmaceutical industry
Websitehbcsbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
189.61M
193.91M
256.10M
219.72M
Cost of goods sold
164.51M
281.46M
193.11M
179.86M
Cost of revenue
164.51M
281.46M
193.11M
179.86M
Research and development expenses
8.72M
9.51M
7.23M
8.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.72M
91.72M
30.76M
30.39M
Operating expense
33.60M
143.40M
38.30M
42.40M
Total operating expenses
198.11M
424.86M
231.40M
222.26M
Operating income
-8.50M
-230.95M
24.70M
-2.54M
Other non operating income
-1.50M
-28.67M
-3.36M
3.51M
EBT including unusual items
-21.20M
-301.55M
5.20M
-24.37M
EBT excluding unusual items
-34.61M
-282.26M
-355.86K
-25.59M
Income tax expense
-435.25K
8.93M
1.82M
761.85K
Effective tax rate
2.05%
-2.96%
35.03%
-3.13%
Other operating expenses
-723.45K
5.43M
2.02M
759.88K
Net income
-15.73M
-313.08M
5.87M
-22.63M
Net profit margin
-8.29%
-161.45%
2.29%
-10.30%
Earnings per share
-
-
-
-
Interest and investment income
2.00M
531.86K
117.28K
28.28K
Interest expense
-19.57M
-28.42M
-21.82M
-23.56M
Net interest expenses
-17.56M
-27.89M
-21.70M
-23.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.49M
-214.14M
41.52M
14.11M
Gain or loss from assets sale
17.64K
228.40K
-
6.30K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps